Dashboard
Manage Tickers

TRDAEntrada Therapeutics, Inc.

Nasdaq entradatx.com


$ 14.87 $ 0.41 (2.84 %)    

Friday, 21-Jun-2024 15:59:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 478.03 $ -1.14 (-0.24 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.75 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 14.85
$ 14.87
$ 0.00 x 0
$ 0.00 x 0
$ 14.60 - $ 14.98
$ 10.75 - $ 18.44
112,350
na
516.65M
$ 0.79
$ 20.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 12-09-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

entrada-therapeutics-to-raise-100m-via-registered-direct-offering-of-34m-shares-at-1485share-to-fund-the-ongoing-clinical-development
Entrada Therapeutics To Raise $100M Via Re...
06/24/2024 11:20:24

Entrada Therapeutics, Inc. (NASDAQ:TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patient...

entrada-therapeutics-announced-preliminary-data-from-its-phase-1-trial-for-entr-601-44-101-in-healthy-volunteers-on-track-to-submit-regulatory-applications-in-q4-2024-to-initiate-separate-two-phase-2-trials-in-duchenne-muscular-dystrophy-patients
Entrada Therapeutics Announced Preliminary...
06/24/2024 10:05:10

ENTR-601-44 was well-tolerated in healthy volunteers with no serious adverse events, no drug-related adverse events and no cl...

entrada-therapeutics-expects-cash-runway-through-the-second-quarter-of-2026-with-327m-in-cash-cash-equivalents-and-marketable-securities-as-of-march-31-2024
Entrada Therapeutics Expects Cash Runway T...
05/07/2024 11:27:43

entrada-therapeutics-q1-2024-gaap-eps-068-may-not-be-comparable-to-052-estimate-sales-59120m-may-not-be-comparable-to-14977m-estimate
Entrada Therapeutics Q1 2024 GAAP EPS $0.6...
05/07/2024 11:26:51

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/11/2024 20:31:16

insiders-buying-americas-car-mart-and-2-other-stocks
Insiders Buying America's Car-Mart And 2 O...
04/11/2024 10:41:15

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

around-5m-bet-on-this-communication-services-stock-check-out-these-4-stocks-insiders-are-buying
Around $5M Bet On This Communication Servi...
03/22/2024 11:29:25

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

hc-wainwright--co-reiterates-buy-on-entrada-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Entr...
03/18/2024 10:38:05

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entrada Therapeutics (NASDAQ:TRDA) with a Buy and maintains $2...

recap-entrada-therapeutics-q4-earnings
Recap: Entrada Therapeutics Q4 Earnings
03/13/2024 13:35:07

entrada-therapeutics-cash-balance-of-352m-with-cash-runway-extended-through-the-second-quarter-of-2026
Entrada Therapeutics' Cash Balance Of $352...
03/13/2024 11:22:51

entrada-therapeutics-q4-gaap-eps-029-misses-017-estimate-sales-4185m-beat-2369m-estimate
Entrada Therapeutics Q4 GAAP EPS $(0.29) M...
03/13/2024 11:21:35

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate o...

oppenheimer-initiates-coverage-on-entrada-therapeutics-with-outperform-rating-announces-price-target-of-22
Oppenheimer Initiates Coverage On Entrada ...
01/05/2024 12:23:52

Oppenheimer analyst Hartaj Singh initiates coverage on Entrada Therapeutics (NASDAQ:TRDA) with a Outperform rating and annou...

hc-wainwright--co-maintains-buy-rating-for-entrada-therapeutics-heres-what-you-need-to-know
HC Wainwright & Co. Maintains Buy Rating f...
11/27/2023 17:00:32

hc-wainwright--co-maintains-buy-on-entrada-therapeutics-lowers-price-target-to-20
HC Wainwright & Co. Maintains Buy on Entra...
11/27/2023 12:26:03

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Entrada Therapeutics (NASDAQ:TRDA) with a Buy and lowers the pr...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
11/23/2023 17:30:58

why-is-neuromuscular-disease-focused-entrada-therapeutics-shares-trading-lower-today
Why Is Neuromuscular Disease Focused Entra...
11/22/2023 19:45:16

Entrada Therapeutics Inc (NASDAQ: TRDA) shares are trading lower after the company announced updates on ENTR-601-44 in 

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
11/22/2023 17:31:08

entrada-says-fda-clinical-hold-on-entr-601-44-ind-application-remains-in-effect-says-informed-that-fda-declined-to-lift-the-clinical-hold
Entrada Says FDA Clinical Hold On ENTR-601...
11/22/2023 12:06:39

entrada-plans-to-announce-data-from-entr-601-44-101-in-h2-of-2024-expects-cash-runway-through-2025
Entrada Plans To Announce Data From ENTR-6...
11/22/2023 12:04:50

entrada-therapeutics-cash-runway-expected-through-2025-with-354m-in-cash-cash-equivalents-and-marketable-securities
Entrada Therapeutics' Cash Runway Expected...
11/07/2023 12:17:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)